Lipid lowering therapy

Video Library

  • Running time: 6 minutes 34 seconds

    Video Library

    The Future of ASCVD and Lipidology with Prof. Cannon

    In this video, Prof. Christopher Cannon explored the future of ASCVD and lipidology. He talks about the recent expanded indication for evlocumab and new indication for inclisiran, upcoming guidelines on LDL management, the development of oral PCSK9 inhibitors, CETP inhibitors, upcoming trials on Lp(a), and strategies for managing triglycerides.

    View

  • Running time: 6 minutes 16 seconds

    Video Library

    The Future of ASCVD and Lipidology with Prof. Bhatt

    In this video, Prof. Deepak Bhatt discusses the future of ASCVD and Lipidology.

    View
View All Lipid lowering therapy Video Library

Infographics

View All Lipid lowering therapy Infographics

Articles

View All Lipid lowering therapy Articles

Case Studies

  • Case Studies

    August 2023

    Take this short quiz to test your knowledge on the recently published debate on dyslipidemias titled “Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers”.

    CLICK HERE TO VIEW THE DEBATE.

    Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275

    Take

  • Case Studies

    Quiz of the month – May 2023

    Take this short quiz to test your knowledge on some of the latest peer-reviewed published literature related to ASCVD and Lipidology.

    Take

  • Case Studies

    Case Study – December 2022

    Our patient case study specially curated for you by our Faculty Member, Prof. Samer Ellahham on concerns about statin associated Diabetes Mellitus.

    Case Study: RS is a 64-year-old Male having dyslipidemia.

     

    Vital parameters:

    BP 144/87 mm Hg

    Low-density lipoprotein cholesterol (LDL-C) 112 mg/dL

    High-density lipoprotein cholesterol (HDL-C) of 47 mg/dL

    Triglycerides 190 mg/dL

    (-) tobacco, (-) alcohol

    Body mass index (BMI) 33 kg/m2

     

    Medication:

    Valsartan 80 mg/d

     

    Family history:

    Father developed type 2 diabetes mellitus (T2DM) and ASCVD at age 58

     

    Labs:

    Fasting blood glucose 103 mg/dL

    HbA1C 5.8%

    Serum Creatinine 1.1 mg/dL

    Urinary analysis within normal limits

     

     

    RS reports that he is reluctant to take statins as they cause diabetes especially with his family history.

    Read More
View All Lipid lowering therapy Case Studies